Silk Road Medical (SILK)

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise the ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and establish temporary blood flow reversal; the ENROUTE Transcarotid Stent System for transcarotid access; and the ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery. Additionally, the company provides the ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for the delivery of interventional devices, as well as the ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. Silk Road Medical, Inc was incorporated in 2007 and is headquartered in Sunnyvale, California. As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation.